β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome (scientific article published on 13 February 2017)

Analysis of T cell responses to the beta 2-glycoprotein I-derived peptide library in patients with anti-beta 2-glycoprotein I antibody-associated autoimmunity

Q30846733

Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.

Q33504706

Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers

Q33766670

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

Q34390132

Role of tissue factor in thrombosis in antiphospholipid antibody syndrome

Q34676688

Inflammation and immunity in diseases of the arterial tree: players and layers

Q34988232

A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome.

Q35124036

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

Q35143874

Autoimmune and inflammatory mechanisms in atherosclerosis

Q35698466

Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis

Q35709096

Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death

Q35745796

Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry

Q35830663

Adaptive Response of T and B Cells in Atherosclerosis

Q35928023

Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity

Q35928650

Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases

Q37057231

Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome

Q37318783

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

Q37368296

Inflammation and plaque vulnerability

Q37370224

Matrix metalloproteinases in atherothrombosis.

Q37708600

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome

Q37721597

Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques

Q37864921

β(2) -Glycoprotein I: evolution, structure and function.

Q37871051

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Q37873720

β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?

Q38008539

Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome

Q38015047

Cardiovascular disease in autoimmune rheumatic diseases.

Q38094402

Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies.

Q38113521

Thrombotic risk in the antiphospholipid syndrome

Q38258485

The challenges of lupus anticoagulants

Q38703934

Metalloproteinase production from macrophages - a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction

Q38771095

Coronary Plaque Disruption

Q40459835

Follicular Helper T Cells

Q40780566

Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression

Q40957024

Complete nucleotide and deduced amino acid sequence of human β2-glycoprotein I

Q41674799

Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection

Q42065742

B7 expression and antigen presentation by human brain endothelial cells: requirement for proinflammatory cytokines.

Q42486013

Circulating T helper and T regulatory subsets in untreated early rheumatoid arthritis and healthy control subjects.

Q50858291

Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts

Q56975282

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

atherosclerosis

Q12252367

P304

page(s)

2640-2648

P577

publication date

2017-02-13

P1433

published in

Journal of Immunology

Q3521441

P1476

title

β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome

P478

volume

198

Reverse relations

cites work (P2860)

Q64056547	Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome
Q91641982	Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells
Q38679842	Antiphospholipid syndrome: an update for clinicians and scientists
Q47554586	HHV-6A Infection of Endometrial Epithelial Cells Induces Increased Endometrial NK Cell-Mediated Cytotoxicity.
Q92369603	Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome
Q64097922	Intrinsic factor recognition promotes T helper 17/T helper 1 autoimmune gastric inflammation in patients with pernicious anemia
Q61796568	LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation
Q91715407	Pediatric antiphospholipid syndrome
Q57821678	Recent Advances in the Development of Vaccines for Diabetes, Hypertension, and Atherosclerosis
Q47819556	The placental bed vascular pathology revisited: a risk indicator for cardiovascular disease
Q93020058	The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS
Q55260402	Tolerogenic β2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.
Q60961044	β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease

P356	DOI	10.4049/JIMMUNOL.1600305
P8608	Fatcat ID	release_2bnqty3ljrhrnlfw2nsnqvei6q
P698	PubMed publication ID	28193831